Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 J+Med+Virol 2020 ; 92 (10): 1875-83 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Predictors of mortality in hospitalized COVID?19 patients: A systematic review and meta?analysis #MMPMID32441789
Tian W; Jiang W; Yao J; Nicholson CJ; Li RH; Sigurslid HH; Wooster L; Rotter JI; Guo X; Malhotra R
J Med Virol 2020[Oct]; 92 (10): 1875-83 PMID32441789show ga
Mortality rates of coronavirus disease?2019 (COVID?19) continue to rise across the world. Information regarding the predictors of mortality in patients with COVID?19 remains scarce. Herein, we performed a systematic review of published articles, from 1 January to 24 April 2020, to evaluate the risk factors associated with mortality in COVID?19. Two investigators independently searched the articles and collected the data, in accordance with PRISMA guidelines. We looked for associations between mortality and patient characteristics, comorbidities, and laboratory abnormalities. A total of 14 studies documenting the outcomes of 4659 patients were included. The presence of comorbidities such as hypertension (odds ratio [OR], 2.5; 95% confidence interval [CI], 2.1?3.1; P?.00001), coronary heart disease (OR, 3.8; 95% CI, 2.1?6.9; P?.00001), and diabetes (OR, 2.0; 95% CI, 1.7?2.3; P?.00001) were associated with significantly higher risk of death amongst patients with COVID?19. Those who died, compared with those who survived, differed on multiple biomarkers on admission including elevated levels of cardiac troponin (+44.2?ng/L, 95% CI, 19.0?69.4; P?=?.0006); C?reactive protein (+66.3?µg/mL, 95% CI, 46.7?85.9; P?.00001); interleukin?6 (+4.6?ng/mL, 95% CI, 3.6?5.6; P?.00001); D?dimer (+4.6?µg/mL, 95% CI, 2.8?6.4; P?.00001); creatinine (+15.3?µmol/L, 95% CI, 6.2?24.3; P?=?.001); and alanine transaminase (+5.7?U/L, 95% CI, 2.6?8.8; P?=?.0003); as well as decreased levels of albumin (?3.7?g/L, 95% CI, ?5.3 to ?2.1; P?.00001). Individuals with underlying cardiometabolic disease and that present with evidence for acute inflammation and end?organ damage are at higher risk of mortality due to COVID?19 infection and should be managed with greater intensity.